London-based health tech startup Thriva has raised a seed round of £1.5 million from a number of funds and investors.
Investors in the seed round include Seedcamp, 500 Startups, London Co-Investment Fund (LCIF), Zoopla CEO Alex Chesterman, Transferwise founder Taavet Hinrikus, and LoveFilm founder Simon Franks.
Thriva has created a home blood testing kit. Users carry out their own finger-prick blood test, which is returned to Thriva and analysed within 48 hours. The results are delivered to the user’s online dashboard where they can monitor their condition and receive GP recommendations. The data is not shared with any third parties the company said.
“Your blood can tell an amazing story about your health,” said CEO Hamish Grierson. “Our mission is to ensure that understanding and tracking your biochemistry becomes as normal as counting your steps or jumping on the weighing scales.”
The company plans on investing the funds into expanding its product range and growing its datasets to improve its machine learning capabilities.
According to a spokesperson for the company, it has generated £250,000 in revenue since June of last year, processing 50,000 tests.
“Since launching to customers in June 2016, Thriva have been earning revenues with a seamless product experience married to clinical-grade testing,” said Tranferwise’s Taavet Hinrikus on his decision to invest in the company.